Close Menu
    What's Hot

    Swiss Re Announces New Longevity Reinsurance Transaction

    March 17, 2026
    Milliman

    US Competitive Pension Risk Transfer Cost Increases in February

    March 16, 2026

    Canada Life Completes Industrials Sector Full Scheme Buy-In

    March 12, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      US Individual Life Insurance New Premium To Set New Sales Record in 2025

      March 4, 2026

      US Life Insurers’ Ample Capital, Liquidity to Support Ratings in 2026

      February 25, 2026

      Higher Sales and Lower Lapse Counts but Rising Exit Values for US Life Insurance Market

      February 11, 2026

      10 Areas To Watch for AI Innovation in Life and Health Underwriting and Claims

      January 28, 2026

      Swiss Re Announces New Longevity Reinsurance Transaction

      March 17, 2026
      Milliman

      US Competitive Pension Risk Transfer Cost Increases in February

      March 16, 2026

      Canada Life Completes Industrials Sector Full Scheme Buy-In

      March 12, 2026

      Achmea Pension & Life Insurance Reinsures Half of Its Longevity Risk

      March 12, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Mortality Rates Scrutiny as Excess Deaths Data Contradicts CMI

      February 11, 2026

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Still Hot and Bothered?

      December 22, 2025

      Update in Delaware Estate Litigation Case Provides Added Clarity to Life Settlement Market

      March 11, 2026

      Regulatory Changes Abound in Offshore US Life/Annuity Sidecar Market but Macro Picture Is the Most Likely Determinant of Further Growth

      March 11, 2026

      Kosmos Management Announces Seventh Asset-Backed Securitisation

      March 5, 2026

      More UK Life Insurer Equity Release Securitisation on the Horizon?

      February 25, 2026

      Swiss Re Announces New Longevity Reinsurance Transaction

      March 17, 2026
      Milliman

      US Competitive Pension Risk Transfer Cost Increases in February

      March 16, 2026

      Canada Life Completes Industrials Sector Full Scheme Buy-In

      March 12, 2026

      Achmea Pension & Life Insurance Reinsures Half of Its Longevity Risk

      March 12, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Life Risk Industry Resilience Provides Confidence to Market

    Life Insurance Capital Solutions May 10, 2022By Greg Winterton
    Covid-19 Resilience
    Share
    Twitter LinkedIn Email
    n

    In public and/or more liquid markets, at the onset of the Covid-19 pandemic, it seemed like everything was correlated; public equities and government bonds all fell sharply as investors sought to liquidate amidst the initial panic. But the panic also spread to the private markets, with private equity portfolio company valuations being written down as investors had to re-model their portfolio company forecasts to adjust to the lockdown environment.

    nn

    Insurance company stock prices certainly took a hit. But in insurance circles, the big question was whether the pandemic was going to be so severe – and cause such an increase in population mortality – that it would damage the entire industry, leaving it in potential need of a government bailout akin to the one received by the banking sector during the Global Financial Crisis (GFC).

    nn

    Since the onset of the pandemic, however, there has been not one bail out or bankruptcy of a major US or UK life insurance company. Nor has there been much of a discussion about the systematic collapse of the life insurance markets.

    nn

    There are two main reasons for this. The first is that the pandemic did not trigger a u2018once in a hundred yearsu2019 event. According to medical journal The Lancet, the Covid-19 infection-fatality ratio was less than 1% for ages 59 years and below. It was 2.6% for persons of age 69, rising to 7.3% for persons aged 79. Those are arguably u2018goodu2019 odds for a life insurance company when modelling a pandemic; at those levels, insurance company mortality risk exposure should be manageable. Although the aforementioned fear factor affected all markets in February and March 2020, the realisation that Covid-19 was not a multi-sigma event came fairly quickly.

    nn

    u201cWhilst there was an initial concern within insurers over the potential size of excess claims, this subsided as emerging data showed relatively modest impacts. Around 60% of our UK clients saw no material impact in their portfolio experience in 2020, with no client experiencing deaths greater than 20% above pre-Covid-19 levelsu201d, said Mark Godson, Partner at EY. u201cAdditionally, for some firms, negative experience in their life insurance portfolios was offset by positive experience in their annuity portfolios.u201d

    nn

    The second reason is that the regulatory infrastructure of the life insurance industry proved to be robust enough to withstand the impact of the Covid-19 pandemic. Much of this infrastructure was implemented or strengthened following the global financial crisis, where governments and financial regulators around the world have sought to adjust the capital requirements of banks, insurance companies and other systemically important organisations to better withstand a multi-sigma event. In Europe, the Solvency II framework, brought into force in 2014, targeted insurance company balance sheets specifically. In the United States, Dodd Frank encompassed insurance companies. Both sets of legislation had – and still have – their critics, but Nicholas Bugler of law firm Willkie, Farr & Gallagher in London argues that whatu2019s not in doubt is that insurance company balance sheets are stronger from a resilience perspective than before the GFC.

    nn

    u201cCertainly, thatu2019s the case,u201d he said. u201cPurely from the perspective of balance sheet fortitude, the changes in the regulations have ensured that insurance company liquidity reserves are larger.u201d

    nn

    The main challenge in the life risk industry turned out to be the same main challenge in most other industries; the need to adapt to working in a lockdown-based environment. In the life settlement corner of the life risk industry, this was certainly the case.

    nn

    u201cWe saw some disruption to our interactions with some brokers, physicians and carriers in the first few months as they transitioned to remote working,u201d said Simon Erritt, Managing Director at Coventry Capital. u201cBut with the accelerated adoption of things like e-signatures, remote notarization and dedicated carrier contacts, the market is definitely operating more efficiently now than before the pandemic.u201d

    nn

    When reflecting on the importance of the life risk markets to the financial system, it is necessary to consider its resilience in the face of world events. Akin to how a devastating hurricane season is disastrous to catastrophe bond holders, a pandemic, in theory, would be similarly challenging to those holders of mortality risk. Life insurance companies provide trillions of dollarsu2019 worth of cover, and are therefore exposed, during a pandemic, to potentially billions of dollars of risk in the form of premature claims. If the underlying life insurance companies – arguably the most important counterparty in a life risk transaction, whether that be a secondary market transaction like life settlements or longevity risk transfer – fail, individual assets in a life risk investment portfolio would lose a substantial amount of their value.

    nn

    But life insurance companies didnu2019t fail. Whether thatu2019s due to the capital restrictions cushion imposed on insurance companies in the wake of the global financial crisis or whether itu2019s because, so far, Covid-19 has not been the u20181 in 100 yearsu2019 event, is unclear. Itu2019s probably a combination of the two. And there is still a chance that new, more aggressive strains of Covid-19 might emerge u2013 or, another virus or disease entirely u2013 that provides a systematic challenge to the life insurance company sector.

    nn

    Thatu2019s not to say that the past two years has been all plain sailing for the insurance industry. The Omicron variant that emerged at the end of 2021 caused yet more disruption to markets and lifestyles, and beyond life risk, property and casualty insurance companies have been hit with business interruption claims.

    nn

    For life risk, though, itu2019s not been anywhere near as bad as it could have been. And what is encouraging for the life risk industry u2013 and the investors, investment managers and service providers that make up the capital marketsu2019 participation in longevity and mortality risk investing u2013 is that, so far, systematic losses have been mitigated.

    nn

    u201cUnderstandably, many in the Life Risk industry were nervous at the outset of the pandemic,u201d said Chris Wells, Executive Director of the European Life Settlement Association. u201cSystematic failure was a real threat and capital requirements had not been truly tested in this manner before. And while the Covid-19 pandemic is not over, and the threat of future pandemics is ever present, the Life Risk industry has demonstrated the ability to withstand these exogenous pressures.u201d

    n
    2022 - May Life ILS Life Settlements Longevity Risk Mortality Risk Volume 1 Issue 1 - May 2022
    Share. Twitter LinkedIn Email

    Related Posts

    Swiss Re Announces New Longevity Reinsurance Transaction

    March 17, 2026By LMI Newsdesk

    Canada Life Completes Industrials Sector Full Scheme Buy-In

    March 12, 2026By LMI Newsdesk

    Achmea Pension & Life Insurance Reinsures Half of Its Longevity Risk

    March 12, 2026By LMI Newsdesk

    Update in Delaware Estate Litigation Case Provides Added Clarity to Life Settlement Market

    March 11, 2026By Greg Winterton
    Latest Issue

    Update in Delaware Estate Litigation Case Provides Added Clarity to Life Settlement Market

    March 11, 2026

    Longevity Swap Activity Expected to Rise as Run-Ons Look More Attractive

    March 11, 2026

    Regulatory Changes Abound in Offshore US Life/Annuity Sidecar Market but Macro Picture Is the Most Likely Determinant of Further Growth

    March 11, 2026

    Defined Benefit Pension Fund Investment Strategies in Focus Amid Gilts-Linked Pension Risk Transfer Pricing

    February 25, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.